BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

  January 30, 2026

   · 

  8 min read
• Press Releases

  KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

  January 30, 2026

   · 

  3 min read
• Press Releases

  LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

  January 30, 2026

   · 

  5 min read
• Press Releases

  MTF Biologics Announces New Funding Opportunities For 2026

  January 30, 2026

   · 

  4 min read
• Press Releases

  Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock

  January 30, 2026

   · 

  4 min read
• Press Releases

  Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

  January 30, 2026

   · 

  1 min read
• Press Releases

  Myosin Therapeutics Invited to Present at Biocom California’s Global Partnering & Investor Conference

  January 30, 2026

   · 

  3 min read
• Press Releases

  Libris Innovations Welcomes Ramani Varanasi as Chief Executive Officer

  January 30, 2026

   · 

  4 min read
• Press Releases

  Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia

  January 30, 2026

   · 

  6 min read
• Press Releases

  MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients

  January 30, 2026

   · 

  7 min read